| Identification | Back Directory | [Name]
1,2,4-Oxadiazol-5(4H)-one, 4-(3-bromo-4- fluorophenyl)-3-[4-[[2-(methylthio)ethyl]amino]- 1,2,5-oxadiazol-3-yl]- | [CAS]
1888341-29-4 | [Synonyms]
IDO-IN-12
IDO inhibitor 12
inhibit,Indoleamine 2,3-Dioxygenase (IDO),Inhibitor,IDOIN12,IDO IN 12
4-(3-bromo-4-fluorophenyl)-3-(4-((2-(methylthio)ethyl)amino)-1,2,5-oxadiazol-3-yl)-1,2,4-oxadiazol-5(4H)-one
1,2,4-Oxadiazol-5(4H)-one, 4-(3-bromo-4- fluorophenyl)-3-[4-[[2-(methylthio)ethyl]amino]- 1,2,5-oxadiazol-3-yl]- | [Molecular Formula]
C13H11BrFN5O3S | [MOL File]
1888341-29-4.mol | [Molecular Weight]
416.23 |
| Chemical Properties | Back Directory | [Boiling point ]
555.9±60.0 °C(Predicted) | [density ]
1.84±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : ≥ 50 mg/mL (120.13 mM) | [form ]
Solid | [pka]
-0.66±0.10(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Description]
IDO-IN-12 is an indoleamine 2,3-dioxygenase (IDO) inhibitor extracted from patent WO 2017181849 A1. | [storage]
Store at -20°C | [References]
[1]. Shenghua Wu, et al. Indoleamine 2,3-dioxygenase inhibitor, preparation method therefor, and application. WO 2017181849 A1. |
|
|